[JANX] YoY Quarter Result on 30-Jun-2021 [#Q2]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -171.72%
YoY- -152.28%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 8,897 1,057 2,365 482 0 -
PBT -5,959 -17,508 -16,888 -6,206 -2,460 24.73%
Tax 0 349 -373 46 -1,136 -
NP -5,959 -17,508 -16,515 -6,206 -2,460 24.73%
Tax Rate - - - - - -
Total Cost 14,856 18,565 18,880 6,688 2,460 56.71%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin -66.98 -1,656.39 -698.31 -1,287.55 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.11 -0.42 -0.40 -0.62 -0.20 -13.87%
EPS Diluted -0.11 -0.42 -0.40 -0.62 -0.20 -13.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.